Laurus Labs Ltd (LAURUSLABS) — Announcement | 18 September 2026

18 September 2026 · BSE 🔴 High Importance Neutral

By StockFin Research Team•AI-Assisted Analysis•Source: BSE/NSE Filings

📢 Key Event

Laurus Labs unveiled its investor presentation detailing FY26 financials and growth strategy

🔄 What Changed

Revenue grew 23% YoY; EBITDA margin improved to 26.8%; CAPEX accelerated to 19% of revenue in Q1 FY27

🔮 What's Next

>30% EBITDA margin from FY27+; CAPEX of ₹3,000+ crores planned for FY27-FY28

💡 Investor Takeaway

The company is aggressively scaling CDMO capabilities and CAPEX to drive higher-margin growth and reduce ARV dependency.

Laurus Labs announced its investor presentation highlighting strong FY26 revenue of ₹6,813 crores, a 23% year-on-year increase, and EBITDA of ₹1,826 crores with a 26.8% margin. The company emphasized accelerated CAPEX of [amount context mismatch] crores in Q1 FY27 (19% of revenue) for capacity expansion in APIs, peptides, fermentation, and gene therapy, targeting >30% EBITDA margin from FY27. It also noted healthy order books, de-risking in ARV revenue, and ESG commitments with SBTi targets.

📄 View Original Announcement (PDF)

📊 Stock Analysis — LAURUSLABS ✨ Ask AI About This

About Laurus Labs Ltd (LAURUSLABS)

Healthcare · Pharmaceuticals · Listed on BSE

Market Cap: ₹1,07,055.86 CrP/E: 97.8ROE: 20.6%ROCE: 20.8%Div Yield: 0.06%

View full LAURUSLABS stock details →

📡 Get AI alerts when LAURUSLABS files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track LAURUSLABS — Free

💡 Ask AI about this filing

"What is the timeline for commissioning the new Vizag fermentation facility?""How will the >30% EBITDA margin target be achieved by FY27?""What specific risks could delay the ADC platform qualification by mid-2027?"

Ask AI Free →

📊 More LAURUSLABS filings

Announcement — 25 September 2026Laurus Labs announced that its trading window closes on October 1, 2026, ahead of unaudited quarterl...
🔴 Announcement — 15 September 2026Laurus Labs announced its participation in Goldman Sachs Healthcare CDMO Day on September 22-24, 202...
🔴 Announcement — 10 September 2026Laurus Labs announced it will attend an in-person investor meeting organized by ICICI Securities in ...
🔴 Announcement — 31 August 2026Laurus Labs announced it will attend the Antique Pharma Investor Day in Hyderabad on September 7, 20...
Announcement — 12 August 2026Laurus Labs announced its participation in the Motilal Oswal Annual Global Investor Conference on Au...

See all LAURUSLABS filings →

🔥 Also filed on 18 September 2026

MAHABANKBank of MaharashtraCorporate Action GODREJINDGodrej Industries LtdCorporate Action THEMISMEDThemis Medicare LtdCorporate Action CREDITACCCreditAccess Grameen LtdCorporate Action ARFINArfin India LtdCorporate Action GUJTHEMGujarat Themis Biosyn LtdCorporate Action

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when LAURUSLABS files new disclosures

Track LAURUSLABS filings, board meetings, and corporate actions. Free email alerts at 5 PM.